Our responsibility, our commitment

Novo Nordisk has been changing diabetes® in Canada since 1984. Today, with more than 200 employees working across the country, our vision is to defeat diabetes by finding better methods of diabetes prevention, detection and treatment. The need has never been more clear.

More than 3 million Canadians are living with diabetes and 6 million more with prediabetes. Every hour of every day, 20 people are diagnosed with diabetes. The burden of the disease, both to the individual and the healthcare system, is growing. By 2020, 10% of Canadians will be living with diabetes, and the burden of the disease will cost the healthcare system close to $17 billion annually.¹

Through our changing diabetes® ambition, Novo Nordisk is making a difference in the lives of people living with diabetes in Canada. Through partnerships with healthcare providers and not-for-profit organizations, we help drive research, advocacy and awareness initiatives to improve access to diabetes education, care and treatment for all Canadians impacted by the disease.

Learn more about how Novo Nordisk is changing diabetes® in Canada in our Corporate Social Responsibility Report.

^{1. An Economic Tsunami: The Cost of Diabetes in Canada; Canadian Diabetes Association, December 2009}